查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1722985

2025 年至 2033 年早期毒性测试市场规模、份额、趋势及按技术、最终用户和地区分類的预测

Early Toxicity Testing Market Size, Share, Trends and Forecast by Technique, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球早期毒性测试市场规模价值 13.7 亿美元。展望未来， IMARC Group估计到 2033 年市场规模将达到 25.7 亿美元，2025 年至 2033 年的复合年增长率为 6.84%。欧洲目前占据市场主导地位，2024 年的市占率将超过 34.0%。受药物开发活动增加、监管要求严格以及替代测试方法进步的推动，市场正在经历显着增长。对预测毒理学解决方案的需求不断增长以及动物试验的减少进一步推动了市场成长，有助于扩大早期毒性测试市场份额。

新化合物的早期毒性测试用于开发药物和扩展现有分子的治疗潜力。它在临床前阶段对各种生物系统进行，以研究产品的物种、器官和剂量特定毒性作用。它可以透过多种方式进行，包括在动物体内进行、在实验室中使用分析进行体外电脑模拟以及在电脑上进行。它也用于研究物质的意外接触。如今，候选药物后期失败的高成本影响促使製药公司对研究产品进行早期毒性测试。

早期毒性测试市场趋势：

接触有毒化学物质是透过皮肤接触、口服或吸入发生的。因此，早期毒性测试已成为各种工业应用中确定产品毒性程度并确保其对人类消费和环境安全的关键过程。例如，它广泛应用于食品和饮料（F&B）行业，以识别不良影响并表征产品中的潜在毒素。此外，疾病盛行率的上升以及对新型药物和生物製品的需求也促使人们采用早期毒性测试，以防止候选药物在临床试验中失败。此外，监管机构实施的与公共健康福利相关的严格规定对早期毒性测试的需求产生了积极影响，以确定监管批准所需药物的可行性。除此之外，农药使用量的增加会对人类健康构成风险，这促进了农业产业使用早期毒性测试。此外，对化妆品的需求不断增长，正在扩大全球化妆品成分早期毒性测试的应用。

本报告回答的关键问题

  • 早期毒性测试市场有多大？早期毒性检测市场未来前景如何？
  • 推动早期毒性测试市场发展的关键因素有哪些？
  • 哪个地区占据最大的早期毒性测试市场份额？
  • 全球早期毒性测试市场领先的公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球早期毒性测试市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依技术

  • 体内
  • 体外
  • 电脑模拟

第七章：市场区隔：依最终用户

  • 製药业
  • 食品工业
  • 化学工业
  • 化妆品产业
  • 其他的

第八章：市场区隔：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第九章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第 13 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • Bruker Corporation
    • Charles River Laboratories International Inc.
    • Danaher Corporation
    • Enzo Biochem Inc.
    • Eurofins Scientific SE
    • Evotec AG
    • Merck KGaA
    • PerkinElmer Inc.
    • SGS SA
    • Thermo Fisher Scientific Inc.
    • WuXi AppTec
Product Code: SR112025A5651

The global early toxicity testing market size was valued at USD 1.37 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 2.57 Billion by 2033, exhibiting a CAGR of 6.84% from 2025-2033. Europe currently dominates the market, holding a market share of over 34.0% in 2024. The market is experiencing significant growth driven by increasing drug development activities, stringent regulatory requirements, and advancements in alternative testing methods. Growing demand for predictive toxicology solutions and reduced animal testing further fuels market growth, contributing to the expanding early toxicity testing market share.

Early toxicity testing of new compounds is used to develop drugs and the extension of the therapeutic potential of existing molecules. It is carried out at pre-clinical stages on various biological systems to investigate the species, organs, and dose-specific toxic effects of a product. It can be performed in multiple ways, including in vivo on animals, in vitro in laboratories using assays, and in silico on a computer. It is also utilized for studying accidental exposures to a substance. Nowadays, the high-cost impact of late-stage failures of drug candidates is encouraging pharma companies to conduct early toxicity testing on investigational products.

Early Toxicity Testing Market Trends:

Exposure to toxic chemicals occurs through skin contact, oral intake, or inhalation. Therefore, early toxicity testing has become a crucial process in various industrial applications for determining the degree of toxicity in products and ensuring that they are safe for human consumption and the environment. For example, it is extensively utilized in the food and beverage (F&B) industry to identify the adverse effects and characterize potential toxicants in products. Moreover, the rising prevalence of diseases and the requirement of novel drugs and biological products are encouraging the adoption of early toxicity testing to prevent the failure of candidate drugs at clinical trials. In addition, stringent regulations relating to public health welfare imposed by regulatory authorities are positively influencing the demand for early toxicity testing to determine the viability of drugs required for regulatory approval. Apart from this, the increasing usage of pesticides can pose risks to human health, which is promoting the use of early toxicity testing in the agriculture industry. Furthermore, the escalating demand for cosmetic products is expanding the application of early toxicity testing of cosmetic ingredients worldwide.

Key Market Segmentation:

Breakup by Technique:

  • In Vivo
  • In Vitro
  • In Silico

Breakup by End User:

  • Pharmaceuticals Industry
  • Food Industry
  • Chemicals Industry
  • Cosmetics Industry
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Charles River Laboratories International Inc., Danaher Corporation, Enzo Biochem Inc., Eurofins Scientific SE, Evotec A.G., Merck KGaA, PerkinElmer Inc., SGS S.A., Thermo Fisher Scientific Inc. and WuXi AppTec.

Key Questions Answered in This Report

  • 1.How big is the early toxicity testing market?
  • 2.What is the future outlook of early toxicity testing market?
  • 3.What are the key factors driving the early toxicity testing market?
  • 4.Which region accounts for the largest early toxicity testing market share?
  • 5.Which are the leading companies in the global early toxicity testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Early Toxicity Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technique

  • 6.1 In Vivo
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 In Vitro
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 In Silico
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Pharmaceuticals Industry
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Food Industry
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Chemicals Industry
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cosmetics Industry
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Bio-Rad Laboratories Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Bruker Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Charles River Laboratories International Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Danaher Corporation
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Enzo Biochem Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Eurofins Scientific SE
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Evotec A.G.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Merck KGaA
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 PerkinElmer Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
    • 13.3.11 SGS S.A.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
    • 13.3.12 Thermo Fisher Scientific Inc.
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
      • 13.3.12.4 SWOT Analysis
    • 13.3.13 WuXi AppTec
      • 13.3.13.1 Company Overview
      • 13.3.13.2 Product Portfolio
      • 13.3.13.3 Financials

List of Figures

  • Figure 1: Global: Early Toxicity Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Early Toxicity Testing Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Early Toxicity Testing Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Early Toxicity Testing Market: Breakup by Technique (in %), 2024
  • Figure 5: Global: Early Toxicity Testing Market: Breakup by End User (in %), 2024
  • Figure 6: Global: Early Toxicity Testing Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Early Toxicity Testing (In Vivo) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Early Toxicity Testing (In Vivo) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Early Toxicity Testing (In Vitro) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Early Toxicity Testing (In Vitro) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Early Toxicity Testing (In Silico) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Early Toxicity Testing (In Silico) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Early Toxicity Testing (Pharmaceuticals Industry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Early Toxicity Testing (Pharmaceuticals Industry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Early Toxicity Testing (Food Industry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Early Toxicity Testing (Food Industry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Early Toxicity Testing (Chemicals Industry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Early Toxicity Testing (Chemicals Industry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Early Toxicity Testing (Cosmetics Industry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Early Toxicity Testing (Cosmetics Industry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Early Toxicity Testing (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Early Toxicity Testing (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: North America: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: North America: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: United States: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: United States: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Canada: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Canada: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Asia-Pacific: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Asia-Pacific: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: China: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: China: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Japan: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Japan: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: India: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: India: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: South Korea: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: South Korea: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Australia: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Australia: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Indonesia: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Indonesia: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Others: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Others: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Europe: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Europe: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Germany: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Germany: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: France: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: France: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: United Kingdom: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: United Kingdom: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Italy: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Italy: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Spain: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Spain: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Russia: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Russia: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Others: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Others: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Latin America: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Latin America: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Brazil: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Brazil: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Mexico: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Mexico: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Middle East and Africa: Early Toxicity Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Middle East and Africa: Early Toxicity Testing Market: Breakup by Country (in %), 2024
  • Figure 71: Middle East and Africa: Early Toxicity Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Global: Early Toxicity Testing Industry: SWOT Analysis
  • Figure 73: Global: Early Toxicity Testing Industry: Value Chain Analysis
  • Figure 74: Global: Early Toxicity Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Early Toxicity Testing Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Early Toxicity Testing Market Forecast: Breakup by Technique (in Million USD), 2025-2033
  • Table 3: Global: Early Toxicity Testing Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 4: Global: Early Toxicity Testing Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Early Toxicity Testing Market: Competitive Structure
  • Table 6: Global: Early Toxicity Testing Market: Key Players